cyclopentane has been researched along with Dengue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, WC; Chen, YH; Hsu, SH; Hung, LC; Lee, JC; Lin, CK; Tseng, CK; Wang, SN; Wang, WH; Wu, YH | 1 |
| Bahador, G; Císařová, I; Deister, E; Ford, L; Hodek, J; Jagtap, PR; Jahn, U; Mackman, R; Pohl, R; Weber, J | 1 |
2 other study(ies) available for cyclopentane and Dengue
| Article | Year |
|---|---|
Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1.
Topics: Animals; Animals, Newborn; Antiviral Agents; Body Weight; Cyclopentanes; Dengue; Dengue Virus; Disease Models, Animal; Heme Oxygenase-1; Mice, Inbred ICR; NF-E2-Related Factor 2; Survival Analysis; Treatment Outcome; Virus Replication | 2018 |
Highly functionalized and potent antiviral cyclopentane derivatives formed by a tandem process consisting of organometallic, transition-metal-catalyzed, and radical reaction steps.
Topics: Antiviral Agents; Catalysis; Cyclopentanes; Dengue; Dengue Virus; Hepacivirus; Hepatitis C; Humans; Isomerism; Models, Molecular; Organometallic Compounds; Transition Elements | 2014 |